Drug intelligence / Profile preview

HIF-1a siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

HIF-1a siRNA refers to a class of small interfering RNA (siRNA) molecules designed to silence the expression of the Hypoxia-Inducible Factor-1 alpha (HIF-1α) gene. HIF-1α is a critical transcription factor that mediates the cellular response to low oxygen (hypoxia), regulating genes involved in glycolysis, angiogenesis, and cell survival. In the context of oncology, HIF-1α is often overexpressed in solid tumors and hematological malignancies, contributing to tumor growth, metastasis, and resistance to chemotherapy and radiation. By utilizing RNA interference (RNAi), HIF-1a siRNA can effectively downregulate HIF-1α protein levels, thereby inhibiting tumor progression and sensitizing cancer cells to therapeutic agents. Various delivery systems, including nanoparticles and viral or bacterial vectors, are being explored in preclinical research to improve the stability and targeted delivery of these siRNA molecules.

Other names
HIF-1alpha siRNAHIF1alpha siRNAHIF 1alpha siRNAHIF1A siRNAHIF-1A siRNAHIF 1A siRNAhypoxia-inducible factor-1 alpha siRNA
02

Targets

HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on HIF-1a siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIF-1a siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call